UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relationship between global severity of patients with Alzheimer's disease and costs of care in Spain; results from the co-dependence study in Spain

The European journal of health economics, 2015-11, Vol.16 (8), p.895-905

2015

Volltextzugriff (PDF)

Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis

Lipids in health and disease, 2018-12, Vol.17 (1), p.277-277, Article 277

2018

Volltextzugriff (PDF)

Situación actual del dolor crónico en España: iniciativa "Pain Proposal"

Revista de la Sociedad Española del Dolor, 2014, Vol.21 (1), p.16-22

2014

Volltextzugriff (PDF)

Qutenza® Estimated Costs Per Patient In Primary Versus Secondary Care. A Comparison Between Qutenza®, Pregabalin and Lidocaine for the Treatment of Peripheral Neuropathic Pain

Value in health, 2014-11, Vol.17 (7), p.A526-A526

2014

Volltextzugriff (PDF)

Patient preferences for osteoporosis in Spain: a discrete choice experiment

Osteoporosis international, 2011-06, Vol.22 (6), p.1947-1954

2011

Volltextzugriff (PDF)

Budget Impact Model of Ceplene® As Maintenance Therapy in Adult Patients with Acute Myeloid Leukemia in First Remission

Value in health, 2014-11, Vol.17 (7), p.A622-A622

2014

Volltextzugriff (PDF)

Budget Impact Analysis of Fentanyl Buccal Tablet for the Treatment of Cancer Breaktrough Pain

Value in health, 2013-11, Vol.16 (7), p.A400-A400

2013

Volltextzugriff (PDF)

Cost-Effectiveness of Glatiramer Acetate and Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis, Based on the Combirx Study

Value in health, 2013-11, Vol.16 (7), p.A623-A623

2013

Volltextzugriff (PDF)

Assessment of potential measures in models of progression in Alzheimer disease

Neurology, 2010-10, Vol.75 (14), p.1256-1262

2010

Volltextzugriff (PDF)

Disability adjusted life years lost due to diabetes in france, Italy, Germany, Spain and the United Kingdom: A burden of illness study

Value in health, 2014-05, Vol.17 (3), p.A262-A262

2014

Volltextzugriff (PDF)

PGI6 A Budget Impact Analysis to Estimate the Economic Impact of Lactest for the Diagnosis of Hypolactasia in Spain

Value in health, 2012-11, Vol.15 (7), p.A327-A327

2012

Volltextzugriff (PDF)

PGI15 Cost-Effectiveness Analysis of Lactest, a New Diagnostic Drug Test for Hypolactasia in Spain

Value in health, 2012-11, Vol.15 (7), p.A328-A328

2012

Volltextzugriff (PDF)

POSC188 Analysis of Hospital Incidence and Direct Medical Costs of Intrahepatic Cholangiocarcinoma in Spain

Value in health, 2022-01, Vol.25 (1), p.S137-S137

2022

Volltextzugriff (PDF)

POSB185 Epidemiology and Management of Parathyroid Gland Disorders in Spain over 15 Years: A Retrospective Multicenter Analysis

Value in health, 2022-01, Vol.25 (1), p.S130-S130

2022

Volltextzugriff (PDF)

POSB184 Hospital Incidence, Mortality and Costs of Alzheimer's Disease in Spain: A Retrospective Multicenter Study

Value in health, 2022-01, Vol.25 (1), p.S130-S130

2022

Volltextzugriff (PDF)

PRS12 A Budget Impact Analysis to Estimate the Economic Impact Of Beclomethasone/Formoterol for the Treatment of Moderate to Severe Persistent Asthma in Six Spanish Regions

Value in health, 2011, Vol.14 (7), p.A489-A489

2011

Volltextzugriff (PDF)

PDG28 Future Projections of Opioids Utilization and Cost in Patient with Chronic Osteoarthritis PAIN in Spain

Value in health, 2020-12, Vol.23, p.S525-S525

2020

Volltextzugriff (PDF)

A Budget Impact Model for Novoseven for the Management of Bleeding Episodes in Patients with Haemophilia a Treated with Inhibitors

Value in health, 2013-11, Vol.16 (7), p.A379-A379

2013

Volltextzugriff (PDF)

Economic Evaluation of the Use of FeNO for the Diagnosis and Management of Asthma Patients in Primary Care in Sweden

ClinicoEconomics and outcomes research, 2021-01, Vol.13, p.289-297

2021

Volltextzugriff (PDF)

PND132 CLAIMS DATABASE ANALYSIS OF HEADACHE AND MIGRAINE IN SPAIN 2011-2016: PATIENT PROFILE, HEALTHCARE MANAGEMENT AND DIRECT MEDICAL COSTS

Value in health, 2019-11, Vol.22, p.S762-S762

2019

Volltextzugriff (PDF)

PDB123 CURRENT STATUS AND USE OF RESOURCES OF LYSOSOMAL STORAGE DISEASES: ANALYSIS OF A SPANISH CLAIMS DATABASE

Value in health, 2019-11, Vol.22, p.S595-S595

2019

Volltextzugriff (PDF)

PCN516 EXPLORING THE CURRENT STATUS OF NEUROENDOCRINE TUMOURS: A POPULATION-BASED ANALYSIS OF EPIDEMIOLOGY, MANAGEMENT AND USE OF RESOURCES

Value in health, 2019-11, Vol.22, p.S538

2019

Volltextzugriff (PDF)

PCV42 A Budget Impact analysis to Estimate the Economic Impact of Sevikarhct® for the Treatment of Arterial Hypertension in Spain

Value in health, 2011, Vol.14 (7), p.A371-A372

2011

Volltextzugriff (PDF)

PIH35 Disability-Adjusted-Life-Years (DALYs) Loss in Postmenopausal Women with Osteoporosis

Value in health, 2012-11, Vol.15 (7), p.A542-A542

2012

Volltextzugriff (PDF)

PSY8 Neuropathic Pain: a Budget Impact Analysis to Estimate Costs Due to the Introduction of Qutenza® on the Spanish Market

Value in health, 2011, Vol.14 (7), p.A411-A411

2011

Volltextzugriff (PDF)

1 – 25 von 133

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(121)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Relationship between global severity of patients with Alzheimer's disease and costs of care in Spain; results from the co-dependence study in Spain

Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis

Situación actual del dolor crónico en España: iniciativa "Pain Proposal"

Qutenza® Estimated Costs Per Patient In Primary Versus Secondary Care. A Comparison Between Qutenza®, Pregabalin and Lidocaine for the Treatment of Peripheral Neuropathic Pain

Patient preferences for osteoporosis in Spain: a discrete choice experiment

Budget Impact Model of Ceplene® As Maintenance Therapy in Adult Patients with Acute Myeloid Leukemia in First Remission

Budget Impact Analysis of Fentanyl Buccal Tablet for the Treatment of Cancer Breaktrough Pain

Cost-Effectiveness of Glatiramer Acetate and Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis, Based on the Combirx Study

Assessment of potential measures in models of progression in Alzheimer disease

Disability adjusted life years lost due to diabetes in france, Italy, Germany, Spain and the United Kingdom: A burden of illness study

PGI6 A Budget Impact Analysis to Estimate the Economic Impact of Lactest for the Diagnosis of Hypolactasia in Spain

PGI15 Cost-Effectiveness Analysis of Lactest, a New Diagnostic Drug Test for Hypolactasia in Spain

POSC188 Analysis of Hospital Incidence and Direct Medical Costs of Intrahepatic Cholangiocarcinoma in Spain

POSB185 Epidemiology and Management of Parathyroid Gland Disorders in Spain over 15 Years: A Retrospective Multicenter Analysis

POSB184 Hospital Incidence, Mortality and Costs of Alzheimer's Disease in Spain: A Retrospective Multicenter Study

PRS12 A Budget Impact Analysis to Estimate the Economic Impact Of Beclomethasone/Formoterol for the Treatment of Moderate to Severe Persistent Asthma in Six Spanish Regions

PDG28 Future Projections of Opioids Utilization and Cost in Patient with Chronic Osteoarthritis PAIN in Spain

A Budget Impact Model for Novoseven for the Management of Bleeding Episodes in Patients with Haemophilia a Treated with Inhibitors

Economic Evaluation of the Use of FeNO for the Diagnosis and Management of Asthma Patients in Primary Care in Sweden

PND132 CLAIMS DATABASE ANALYSIS OF HEADACHE AND MIGRAINE IN SPAIN 2011-2016: PATIENT PROFILE, HEALTHCARE MANAGEMENT AND DIRECT MEDICAL COSTS

PDB123 CURRENT STATUS AND USE OF RESOURCES OF LYSOSOMAL STORAGE DISEASES: ANALYSIS OF A SPANISH CLAIMS DATABASE

PCN516 EXPLORING THE CURRENT STATUS OF NEUROENDOCRINE TUMOURS: A POPULATION-BASED ANALYSIS OF EPIDEMIOLOGY, MANAGEMENT AND USE OF RESOURCES

PCV42 A Budget Impact analysis to Estimate the Economic Impact of Sevikarhct® for the Treatment of Arterial Hypertension in Spain

PIH35 Disability-Adjusted-Life-Years (DALYs) Loss in Postmenopausal Women with Osteoporosis

PSY8 Neuropathic Pain: a Budget Impact Analysis to Estimate Costs Due to the Introduction of Qutenza® on the Spanish Market

Suchergebnisse filtern